Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case
Agustín Buero, Silvia Quadrelli, Leonardo German Pankl and 1 more
The Pan African Medical Journal · 2019
doi:10.11604/pamj.2019.33.53.12401 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment. As it's extremely rare, there is no evidence of the impact of different modalities of treatment. There are no reported cases that did not include surgery as part of their management. We herein present a case of an unresectable thymic basaloid carcinoma treated only with concurrent chemotherapy and radiotherapy that obtained a complete remission and free of disease after 2 years.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.